TOP > 外国特許検索 > COLORECTAL CANCER DIAGNOSTIC MARKER, METHOD FOR ASSISTING DIAGNOSIS OF COLORECTAL CANCER, METHOD FOR COLLECTING DATA FOR DIAGNOSIS OF COLORECTAL CANCER, COLORECTAL CANCER DIAGNOSTIC KIT, THERAPEUTIC AGENT FOR COLORECTAL CANCER, METHOD FOR TREATING COLORECTAL CANCER, AND METHOD FOR DIAGNOSING COLORECTAL CANCER

COLORECTAL CANCER DIAGNOSTIC MARKER, METHOD FOR ASSISTING DIAGNOSIS OF COLORECTAL CANCER, METHOD FOR COLLECTING DATA FOR DIAGNOSIS OF COLORECTAL CANCER, COLORECTAL CANCER DIAGNOSTIC KIT, THERAPEUTIC AGENT FOR COLORECTAL CANCER, METHOD FOR TREATING COLORECTAL CANCER, AND METHOD FOR DIAGNOSING COLORECTAL CANCER

Foreign code F210010361
File No. (S2019-0533-N0)
Posted date 2021年4月26日
Country 世界知的所有権機関(WIPO)
International application number 2020JP030676
International publication number WO 2021033605
Date of international filing 令和2年8月12日(2020.8.12)
Date of international publication 令和3年2月25日(2021.2.25)
Priority data
  • 特願2019-149338 (2019.8.16) JP
Title COLORECTAL CANCER DIAGNOSTIC MARKER, METHOD FOR ASSISTING DIAGNOSIS OF COLORECTAL CANCER, METHOD FOR COLLECTING DATA FOR DIAGNOSIS OF COLORECTAL CANCER, COLORECTAL CANCER DIAGNOSTIC KIT, THERAPEUTIC AGENT FOR COLORECTAL CANCER, METHOD FOR TREATING COLORECTAL CANCER, AND METHOD FOR DIAGNOSING COLORECTAL CANCER
Abstract The present invention provides: a colorectal cancer diagnostic marker which can determine the presence or absence of colorectal cancer morbidity with high accuracy and which can also detect early colorectal cancer with high sensitivity; a method which is for assisting the diagnosis of colorectal cancer, and measures the expression level of the colorectal cancer diagnostic marker, a method for collecting data to diagnose colorectal cancer, a method for diagnosing colorectal cancer; a method for treating colorectal cancer; a colorectal cancer diagnostic kit including the colorectal cancer diagnostic marker and a specific primer; and a therapeutic agent containing an inhibitor of the colorectal cancer diagnostic marker. The colorectal cancer diagnostic marker according to the present invention is at least one microRNA selected from the group consisting of hsa-miR-129-1-3p, hsa-miR-566, and hsa-miR-598-5p.
Outline of related art and contending technology BACKGROUND ART
Lower gastrointestinal endoscopy and fecal heath testing are known as methods for examining the presence or absence of colon cancer (for example, Non-Patent Documents 1 and 2). Lower gastrointestinal endoscopy takes longer to examine, is highly invasive, and also costly to examine. Therefore, lower gastrointestinal endoscopy is not recommended for medical examinations and screening tests for healthy individuals. As a result of the above, fecal latent blood tests are often performed in the examination of colon cancer or the like. In addition, CEA (carcinoembryonicantigen) and CA19-9 (carbohydrate antigen 19-9) are known as biomarkers for colon cancer.
  • Applicant
  • ※All designated countries except for US in the data before July 2012
  • NAGOYA CITY UNIVERSITY
  • Inventor
  • SHIMURA Takaya
  • IWASAKI Hiroyasu
  • KATAOKA Hiromi
IPC(International Patent Classification)
Specified countries National States: AE AG AL AM AO AT AU AZ BA BB BG BH BN BR BW BY BZ CA CH CL CN CO CR CU CZ DE DJ DK DM DO DZ EC EE EG ES FI GB GD GE GH GM GT HN HR HU ID IL IN IR IS IT JO JP KE KG KH KN KP KR KW KZ LA LC LK LR LS LU LY MA MD ME MG MK MN MW MX MY MZ NA NG NI NO NZ OM PA PE PG PH PL PT QA RO RS RU RW SA SC SD SE SG SK SL ST SV SY TH TJ TM TN TR TT TZ UA UG US UZ VC VN WS ZA ZM ZW
ARIPO: BW GH GM KE LR LS MW MZ NA RW SD SL SZ TZ UG ZM ZW
EAPO: AM AZ BY KG KZ RU TJ TM
EPO: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
OAPI: BF BJ CF CG CI CM GA GN GQ GW KM ML MR NE SN ST TD TG
ライセンスをご希望の方、特許の内容に興味を持たれた方は、問合せボタンを押してください。

PAGE TOP

close
close
close
close
close
close